Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
Clinical trial NCT04349293 · UNKNOWN
Trial details
- NCT number
- NCT04349293
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-08
- Primary completion
- 2021-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.